rs146993892

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006493.4(CLN5):​c.5C>T​(p.Ala2Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000385 in 1,611,760 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A2A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00049 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00037 ( 2 hom. )

Consequence

CLN5
NM_006493.4 missense

Scores

2
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:7

Conservation

PhyloP100: -0.262

Publications

5 publications found
Variant links:
Genes affected
CLN5 (HGNC:2076): (CLN5 intracellular trafficking protein) This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.[provided by RefSeq, Oct 2008]
CLN5 Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 5
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet, G2P, Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056524277).
BP6
Variant 13-76992103-C-T is Benign according to our data. Variant chr13-76992103-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 205125.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006493.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN5
NM_006493.4
MANE Select
c.5C>Tp.Ala2Val
missense
Exon 1 of 4NP_006484.2O75503
CLN5
NM_001366624.2
c.5C>Tp.Ala2Val
missense
Exon 1 of 5NP_001353553.1A0A1B0GTR6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN5
ENST00000377453.9
TSL:1 MANE Select
c.5C>Tp.Ala2Val
missense
Exon 1 of 4ENSP00000366673.5O75503
CLN5
ENST00000636183.2
TSL:1
c.5C>Tp.Ala2Val
missense
Exon 1 of 4ENSP00000490181.2O75503
ENSG00000283208
ENST00000638147.2
TSL:5
c.5C>Tp.Ala2Val
missense
Exon 1 of 5ENSP00000490953.2A0A1B0GWJ7

Frequencies

GnomAD3 genomes
AF:
0.000486
AC:
74
AN:
152230
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.0156
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000694
AC:
163
AN:
234904
AF XY:
0.000719
show subpopulations
Gnomad AFR exome
AF:
0.0000705
Gnomad AMR exome
AF:
0.0000586
Gnomad ASJ exome
AF:
0.0134
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000245
Gnomad OTH exome
AF:
0.000690
GnomAD4 exome
AF:
0.000374
AC:
546
AN:
1459530
Hom.:
2
Cov.:
35
AF XY:
0.000402
AC XY:
292
AN XY:
726102
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33408
American (AMR)
AF:
0.0000672
AC:
3
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.0134
AC:
348
AN:
26062
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39656
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86182
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52384
Middle Eastern (MID)
AF:
0.000359
AC:
2
AN:
5576
European-Non Finnish (NFE)
AF:
0.0000972
AC:
108
AN:
1111376
Other (OTH)
AF:
0.00129
AC:
78
AN:
60234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000486
AC:
74
AN:
152230
Hom.:
2
Cov.:
33
AF XY:
0.000444
AC XY:
33
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41468
American (AMR)
AF:
0.000131
AC:
2
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0156
AC:
54
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68038
Other (OTH)
AF:
0.00191
AC:
4
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000832
Hom.:
1
Bravo
AF:
0.000427
ESP6500AA
AF:
0.000229
AC:
1
ESP6500EA
AF:
0.000587
AC:
5
ExAC
AF:
0.000548
AC:
66
EpiCase
AF:
0.000382
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
2
Neuronal ceroid lipofuscinosis (2)
-
1
1
Neuronal ceroid lipofuscinosis 5 (2)
-
-
1
Inborn genetic diseases (1)
-
1
-
Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
14
DANN
Uncertain
1.0
DEOGEN2
Benign
0.062
T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.58
T
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.26
PrimateAI
Uncertain
0.74
T
REVEL
Benign
0.029
Polyphen
0.086
B
MVP
0.40
MPC
0.52
ClinPred
0.047
T
GERP RS
1.9
PromoterAI
-0.36
Neutral
Varity_R
0.057
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146993892; hg19: chr13-77566238; COSMIC: COSV66284048; COSMIC: COSV66284048; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.